
C221H342N46O68
TRIVEXA
Retatrutide
TRIVEXA is presented within HMD as an investigational system for scientific reading and molecular characterization. This profile connects the molecule with related historical and technical documentation within the HMD series.
| Type | Triple GIP, GLP-1 and glucagon receptor agonist |
|---|---|
| Chemical / scientific name | Synthetic 39-amino-acid peptide with complex structural modifications and a lipid side chain intended to prolong exposure. |
| Molecular formula | C221H342N46O68 |
Technical profile
This profile is part of a documentary library of investigational systems. It does not constitute a clinical indication, therapeutic recommendation, prescription, commercial availability, or instructions for use.
Related literature
Research dossier
HMD-ED-003 — TRIVEXA Evidence Dossier
Retatrutide · Full Technical Brief. Document viewer for client-facing technical consultation, integrated into the molecular profile of the investigational system.
Loading dossier...
